Ο καρκίνος της ουροδόχου κύστης είναι η τέταρτη συχνότερη κακοήθεια στους άνδρες και η δέκατη στις γυναίκες και η ετήσια επίπτωσή του αυξάνει συνεχώς στις ανεπτυγμένες χώρες. Oι προγνωστικοί παράγοντες που χρησιμοποιούνται σήμερα δεν μπορούν να προβλέψουν με βεβαιότητα την μακροπρόθεσμη έκβαση του ουροθηλιακού καρκίνου και έτσι προκύπτει η ανάγκη αναγνώρισης δεικτών με δυνατότητα πρόγνωσης της συμπεριφοράς των καρκινωμάτων. Επιπλέον, δεδομένων των περιορισμένων δυνατοτήτων των σημερινών θεραπευτικών επιλογών (χειρουργική αντιμετώπιση, χημειοθεραπεία ή ανοσοθεραπεία και ακτινοθεραπεία), απαιτούνται νέες θεραπευτικές στρατηγικές. Μία τέτοια στρατηγική είναι η στόχευση σε μεταγραφικούς παράγοντες όπως οι πυρηνικοί υποδοχείς και οι upstream ενεργοποιητές τους. Η διαταραχή αυτών των μεταγραφικών παραγόντων είναι κομβικό σημείο της έναρξης και διατήρησης του κακοήθους φαινοτύπου. O πυρηνικός υποδοχέας PPARγ εμπλέκεται στον έλεγχο του μεταβολισμού, την κυτταρική ανάπτυξη, την αγγειογένεση και την ανοσολογική και φλεγμονώδη απάντηση. Επιπρόσθετα, υπάρχουν ενδείξεις ότι ρυθμίζει τους μηχανισμούς καταστολής αλλά και προαγωγής της καρκινογένεσης. Ο RXRα είναι επίσης μέλος της υπεροικογένειας των πυρηνικών υποδοχέων και ετεροδιμερίζεται με τον PPARγ προς σχηματισμό του συμπλόκου που αλληλεπιδρά με το DNA. Οι προσδέτες των RXR υποδοχέων έχουν ήδη χρησιμοποιηθεί στη χημειοπρόληψη διαφόρων μορφών καρκίνου. Ο μεταγραφικός παράγoντας AP-1, απαρτίζεται από διμερή των Fos και Jun πρωτεϊνών και η δράση του σχετίζεται με την πρόοδο της καρκινογένεσης. Υπάρχουν πάντως και ενδείξεις για προ-αποπτωτική δράση του. Η CBP είναι ένας απ’ τους σημαντικότερους ολοκληρωτές σημάτων της μεταγραφής. Ο ανταγωνισμός μεταξύ των PPARγ και AP-1 για τη CBP είναι ένας απ’ τους μηχανισμούς που εξηγούν την αρνητική «συνομιλία» (cross-talk) μεταξύ των PPARγ και AP-1. Στην παρούσα μελέτη εξετάσαμε τόσο ξεχωριστά όσο και σε συνδυασμό μεταξύ τους, την έκφραση των πέντε μοριακών παραγόντων (PPARγ, RXRα, p-c-Jun, c-Fos, CBP) στο φυσιολογικό ουροθήλιο, τις προκαρκινικές αλλοιώσεις και τα ουροθηλιακά καρκινώματα (ΟΚ). Τα ιστικά δείγματα προήλθαν από 88 ασθενείς οι οποίοι υπέστησαν διαγνωστική βιοψία ή θεραπευτική κυστεκτομή, νεφρεκτομή ή ουρητηρεκτομή. Εφαρμόστηκε η ανοσοϊστοχημική μέθοδος σε τομές παραφίνης και εκτιμήθηκε η σχετική έκφραση των μελετώμενων παραγόντων στα ενδοκυττάρια διαμερίσματα, τις ενδοεπιθηλιακές στιβάδες και τις φυσιολογικές ή παθολογικές ιστολογικές βαθμίδες. Όλοι οι παράγοντες παρουσίασαν κυρίως πυρηνική εντόπιση. Η έκφραση του p-c-Jun ελαττώνεται στους ασθενείς άνω των 70 ετών σε σχέση με τους νεώτερους, ενώ κανένα άλλο απ’ τα μελετώμενα μόρια δε φαίνεται να επηρεάζεται από την ηλικία. Η έκφραση των PPARγ, CBP, p-c-Jun και c-Fos σημειώνει αύξηση κατά την πορεία προς τον καρκίνο. Όσο αφορά στα ΟΚ, οι PPARγ και CBP παρουσιάζουν αρνητική συσχέτιση με την αποδιαφοροποίηση. Επιπλέον ο PPARγ συσχετίζεται αρνητικά με την απόκτηση χαρακτήρων διήθησης στα ΟΚ. Αντιθέτως, η έκφραση του RXRα δεν διακυμαίνεται στατιστικώς σημαντικά σε όλη την πορεία της καρκινογένεσης. Η ανάλυση της συνδυασμένης έκφρασης των πέντε παραγόντων έγινε με σκοπό την αποκάλυψη ενδεχόμενων αλληλεπιδράσεων μεταξύ τους. Η προστατευτική δράση του PPARγ στο ουροθήλιο συνοδεύεται από ταυτόχρονη μέτρια ή ισχυρή έκφραση των RXRα, p-c-Jun και c-Fos. Αναλυτικά, η αυξανόμενη έκφραση του p-c-Jun συμπίπτει με ενίσχυση της θετικής συσχέτισης του PPARγ με καλύτερα διαφοροποιημένους, λιγότερο διηθητικούς όγκους, ενώ ο c-Fos φαίνεται να εξασθενίζει ήπια την ευνοϊκή δράση του PPARγ στη διαφοροποίηση του ουροθηλίου. Η αυξανόμενη έκφραση της CBP έδειξε να εξασθενίζει και τελικά να εκμηδενίζει τη στατιστικά σημαντική αύξηση του PPARγ στην πορεία προς τον καρκίνο και την επαγωγή του στους μη διηθητικούς όγκους σε σύγκριση με τους διηθητικούς. Ταυτόχρονα, η αρνητική σχέση της CBP με την αποδιαφοροποίηση και την αύξηση της κακοήθειας των ΟΚ επηρεάζεται από την παρουσία των PPARγ και AP-1, επιβεβαιώνοντας την υπόθεση της συνομιλίας αυτών των μοριακών παραγόντων. Ενδιαφέρουσα είναι η παρατήρηση ότι οι περισσότερες από τις αναφερθείσες πιο πάνω συσχτίσεις μεταξύ των μοριακών παραγόντων ίσχυαν για μεγαλύτερους των 70 ετών αλλά όχι πάντα για τους νεώτερους ασθενείς. Τα αποτελέσματα της παρούσας μελέτης μπορούν πιθανόν να οδηγήσουν σε συμπεράσματα με εφαρμογή σε χημειοπροληπτικές και θεραπευτικές στρατηγικές για τον ουροθηλιακό καρκίνο. / Bladder cancer is the fourth and tenth most common malignancy in men and women, respectively, and its incidence is increasing annually in the developed countries. Current prognostic parameters cannot predict with certainty the long-term outcome of bladder cancer and as a result there is a need to identify markers that may predict tumor behavior. Furthermore, given the limitations of current therapeutic options (surgery, chemotherapy or immunotherapy and radiotherapy), novel treatment strategies are very much needed. One such strategy targets transcription factors such as nuclear receptors and their upstream activators. Disruption of these transcription factors is a key element in the initiation and maintenance of a malignant phenotype. The nuclear receptor PPARγ is involved in controlling metabolism, cell growth, angiogenesis, and immune and inflammatory responses. In addition, it has also been suggested that it regulates tumor suppression as well as tumor promotion. RXRα is another member of the nuclear receptor superfamily, that partners PPARγ to form the DNA-binding complex. RXR ligands are already being used as chemopreventive agents in various types of cancer. The transcription factor AP-1 is formed by dimerization of Jun and Fos proteins and its activity is often associated with tumor progression. On the other hand, there is also evidence that AP-1 may enhance apoptosis. CBP is one of the most important transcriptional integrators. The competition of PPARγ and AP-1 for CBP is one of the multiple mechanisms that explain the negative PPARγ/AP-1 cross-talk. In the present study, we assessed separate and concurrent expression of the five factors (PPARγ, RXRα, p-c-Jun, c-Fos, CBP) in normal urothelium, precancerous lesions and urothelial carcinomas (UC). Clinical samples were derived from 88 patients who had undergone diagnostic biopsy or therapeutic excision of the bladder, the kidney or the ureter. Parafin section immunohistochemistry was utilized and relative expression was estimated in intracellular compartments, intraepithelial layers and histologic categories of urothelium. All five factors had mainly nuclear pattern of expression. P-c-jun was downregulated in patients older than 70 years old compared to younger ones, whereas age did not affect the expression of the rest four factors. PPARγ, CBP, p-c-Jun and c-Fos were upregulated towards tumorigenesis. PPARγ and CBP showed an inverse relationship with carcinoma level of differentiation. Moreover, PPARγ expression downregulated significantly in invasive tumors compared to non-invasive ones. On the contrary, RXRα expression did not vary significantly along the carcinogenesis course. The following correlations were based on coexpression analysis to reveal molecular interactions between the five factors. The established protective effect of PPARγ on urothelium was accompanied by concomitant RXRα, p-c-Jun and c-Fos moderate or strong expression. In detail, p-c-Jun’s increasing expression strengthened the positive relation of PPARγ with better differentiated, less invasive tumors, whereas c-Fos seemed to mildly lessen PPARγ’s favourable effect in urothelium differentiation. Statistically significant PPARγ upregulation in malignant tissues compared to normal urothelium and in non-invasive tumors compared to invasive ones is suppressed and finally cancelled by CBP’s increasing expression. PPARγ and AP-1 seemed to influence the negative relation of CBP with loss of differentiation and increase of malignant potential in UC, an observation that denotes a cross-talk between these molecular factors. Interestingly, most of the aforementioned correlations were noticed in patients older than 70 years old, but not all of them were plausible in younger patients. The results from the present study could lead to conclusions possibly applicable in chemoprevention and therapy strategies for urothelial carcinomas.

Conselho Nacional de Desenvolvimento Científico e Tecnológico / Spontaneous cases of chronic poisoning by Pteridium aquilinum in cattle were studied. The clinical forms of the disease were squamous cell carcinoma (SCCs) of the upper digestive tract (UDT) and bovine enzootic hematuria (BEH). The cases were from the midland Region of the Midwest of Rio Grande do Sul State, Brazil. For the epidemiological study, the profile of the farms was analyzed about herd purpose, main activity of the farm, altitude, and area of plant infestation. No differences were observed among the clinical forms, according to these criteria. Analysis of the ager, gender, and breed of the affected cattle revealed that, in both clinical forms of disease, mixed breed cows (more common in that region) were more affected. In BEH, adult cattle (3-to-7-years-old) were more frequently affected. In the form of UDT SCCs, aged cattle (more than 8- years-old) were more affected. For the clinical study, clinical signs and blood work were evaluated at terminal phase of disease. Cattle with UDT SCCs, had progressive weigth loss, ruminal atony, cough, dysphagia, bloating, and regurgitation. Hematuria was clinically observed in one case of this disease form. In cattle with BEH, hematuria was observed in all cases, followed by progresive weigth loss. Non-regenerative anemia was detected in 33.33% in UDT SCCs form and in 66.66% of BEH form. Changes in white blood count occurred in some cases but drop in lymphocytes was uncommon in both forms of disease. For the morfological study, urinary bladders of 46 UDT SCCs cases and 11 BEH cases were analyzed. Grossly, 16/46 bladders of the UDT SCCs form had gross lesions (vesical red or pale nodules, hemorrhages, and papilomas; red urine in the three cases). In BEH form, the bladder had nodules, large neoplastic masses, red urine, papilomas, and hemorrhages. Pielonephritis and hidronephosis were seen in a few cases. Microscopically, in the UDT SCCs form, 44/46 (95.65%) bladders had 22 different types of morphological changes, caracterized by neoplastic lesions (5/22) and non-neoplastic lesions (17/22), which were subdivided in non-neoplastic epithelial changes (6/17), general changes of the lamina propria (6/17), and inflammatory changes (5/17). The bladder changes in BEH form were of 19 different types, caracterized by neoplastic lesions (5/19) and non-neoplastic lesions (14/19), which were subdivided in non-neoplastic epitelial changes (9/14), general changes of the lamina propria (3/14), and inflammatory changes (2/14). In BEH, mesenchymal neoplasms were more observed than epithelial ones, and most of them were malignant. Immunohistochemistry was utilized to characterize the histogenesis of poorly differentiated neoplasms. In conclusion, the morfological study showed that urinary bladder lesions are very often in cattle with the UDT SCCs form, and were identical to the ones seen in cattle with BEH. / Foram estudados casos espontâneos de intoxicação crônica por samambaia em bovinos nas formas clinicopatológicas de carcinoma de células escamosas (CCE) no trato alimentar superior (TAS) e de hematúria enzoótica bovina (HEB), provenientes da Mesorregião Centro Ocidental do Rio-Grandense e encaminhados ao Laboratório de Patologia Veterinária (LPV) da Universidade Federal de Santa Maria (UFSM). Para o estudo epidemiológico, foi avaliado o perfil das propriedades quanto à finalidade da criação, principal atividade da propriedade, altitude e área de infestação pela planta. Quanto a esses parâmetros, as propriedades com uma ou outra forma de intoxicação crônica não apresentaram diferenças. Foi determinado o perfil dos bovinos afetados quanto à idade, sexo e raça. Os mais afetados por ambas as formas clínicas foram fêmeas de raça mista (predominante na região). Na HEB houve predomínio de bovinos adultos (três a sete anos) e a forma de CCEs no TAS afetou mais bovinos idosos (mais de oito anos). Para o estudo clínico foram avaliados os sinais clínicos de bovinos com CCEs no TAS e com HEB e realizados hemogramas na fase terminal da doença. Os principais sinais clínicos nos bovinos com CCEs no TAS foram emagrecimento progressivo, atonia ruminal, tosse, disfagia, timpanismo, regurgitação e hematúria, vista em um caso. Nos bovinos com HEB, hematúria foi o principal sinal, observado em todos os casos, seguido de emagrecimento progressivo. No exame hematológico, 33,33% dos bovinos com CCEs no TAS e 66,67% dos bovinos com HEB apresentaram anemia arregenerativa. Alterações no leucograma ocorreram em alguns casos, mas linfopenia foi um achado infreqüente em ambas as formas de intoxicação. Para o estudo morfológico, foram avaliadas as bexigas de 46 casos de CCEs no TAS e de 11 casos de HEB. Macroscopicamente, 16/46 bexigas dos casos de CCEs no TAS apresentaram alterações macroscópicas, que foram nódulos vermelhos ou pálidos, hemorragia e papilomas; urina vermelha foi observada em três casos. Nos casos de HEB, os achados macroscópicos vesicais foram nódulos vermelhos, massas neoplásicas focalmente extensas, urina vermelha, papilomas, hemorragias e ruptura de bexiga; pielonefrite e hidronefrose foram observados em poucos casos. Histologicamente, 44/46 (95,65%) bexigas de bovinos com CCEs no TAS apresentaram 22 tipos diferentes de alterações morfológicas, que foram classificadas em alterações neoplásicas (5/22) e alterações não-neoplásicas (17/22), as quais foram divididas em alterações epiteliais não-neoplásicas (6/17), alterações gerais na lâmina própria (6/22) e alterações inflamatórias (5/17). Os achados histológicos das bexigas dos casos de HEB foram classificados da mesma forma, resultando em 19 tipos diferentes de alterações morfológicas. Dessas, 5/19 eram alterações neoplásicas e 14/19, alterações não-neoplásicas (9/14 alterações epiteliais não neoplásicas, 3/14 alterações gerais na lâmina própria e 2/14 alterações inflamatórias). Na HEB, os neoplasmas mesenquimais foram mais observados que os epiteliais, e a maior parte era maligno. A técnica de imuno-histoquímica foi utilizada para caracterizar os aspectos morfológicos, principalmente dos neoplasmas. Através do estudo morfológico concluiu-se que é muito freqüente a ocorrência de lesões vesicais em bovinos com a forma crônica de CCEs no TAS e que essas são idênticas às encontradas nos bovinos com HEB.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / To determine the main factors influencing the biological behavior of 40 squamous cell carcinomas (SCC) of the upper digestive tract (UDT) of cattle associated with spontaneous ingestion of bracken fern (Pteridium aquilinum), morphological, including cell proliferation, and immunohistochemical aspects were studied. The aspects analyzed included anatomical localization of SCCs, degree of differentiation, occurrence and distribution of metastasis, intensity of the lymphoplasmocytic inflammatory infiltrate (LPII), of the desmoplastic reation, tumor-associated tissue eosinophilia, and the cell proliferation index evaluated through quantification of the argyrophilic nucleolar organizer regions (AgNORs). Forty two percent of SCCs were in the cranial region, 12.5% in the middle, and 45% in the caudal region of the UDT. The neoplasms were classified as well differentiated (WD-SCC; 67.5%), moderately differentiated (MD-SCC; 20%), or poorly differentiated (PD-SCC; 12.5%). When the degree of differentiation was correlated to the anatomical localization, it was observed in the cranial region that 88.2% were WD-SCC and 11.8% were MD-SCC. In the middle region, 60% were WD-SCC, 20% were MD-SCC, and 20% were PD-SCC. In the caudal region, 50% were WD-SCC, 27,8% were MD-SCC, and 22,2% were PD-SCC. Metastasis occurred in 57.75% of the cases, mostly to regional lymph nodes, and were observed in 58.82% of the cases with SCCs of the cranial region; in 40% of the middle region, and in 61.11% of the caudal region. Metastasis to regional lymph nodes and/or to distant organs were found in 44.44% of WDSCC, 75% of MD-SCC, and 100% of PD-SCC. Migration and invasion patterns were analyzed through the immunohistochemistry technique for cytokeratin. Islands and ribbons of neoplastic keratinocytes predominated in the WD-SCCs. The patterns varied greatly in the MD-SCCs, although small aggregates, ribbons, and cords predominated. PD-SCCS were characterized by small aggregates and individual cells. Lymphatic or hematogenous invasion were detected in 11/40 SCCs. There were SCCs originating from the ductal epithelium of the salivary glands. This finding was not previously reported. The intensity of the LPII was more accentuated in the BD-SCCs than in the MDs or PDs. The intensity of the desmoplastic reaction was quantified through the immunohistochemistry technique for vimentin, and was more severe in the PD-SCCs. The tumor-associated tissue eosinophilia (TATE) was measured in the SCCs and classified as mild, moderate, or severe. The only positive statistically significant association was established between TATE and LPII intensities. Cell proliferation was evaluated through quantification of the argyrophilic nucleolar organizer regions (AgNORs) on the neoplastic keratinocytes. AgNOR mean value and standard deviation (±sd) for WD-SCCs were 1.65 (±0.23), for MD-SCCs were 1.88 (±0.31), and for PD-SCCs were 2.39 (±0.26). The correlation between the AgNOR index and each histopathological grade was statistically significant. In conclusion, the factors which influenced the biological behavior of SCCs were the degree of cell differentiation, the patterns of migration and invasion, the intensity of LPII, TATE and desmoplastic reation, and the cell proliferation index measured through quantification of the AgNORs. / Aspectos morfológicos, incluindo proliferação celular, e imunoistoquímicos de 40 carcinomas de células escamosas (CCEs) do trato alimentar superior de bovinos que consumiram samambaia (Pteridium aquilinum) espontaneamente foram estudados, visando principalmente determinar os fatores que influenciam o comportamento biológico destes neoplamas. Os aspectos analisados incluíram localização anatômica dos CCEs, grau de diferenciação celular, ocorrência e distribuição de metástases, padrões de migração e invasão, intensidade do infiltrado inflamatório linfoplasmocítico (IILP), da reação desmoplásica e da eosinofilia tecidual associada a tumores (TATE), e o índice de proliferação celular avaliado através da contagem das regiões organizadoras nucleolares argirofílicas (AgNORs). Quanto a localização anatômica, 42% dos CCEs localizaramse na região cranial, 12,5% na média e 45% na caudal do trato alimentar superior (TAS). Os CCEs foram classificados quanto ao grau de diferenciação celular em bem (CCE-BD [67,5%]), moderadamente (CCE-MD [20%]) ou pouco diferenciados (CCE-PD [12,5%]). Quando relacionado o grau de diferenciação celular com a localização no TAS, verificou-se que na região cranial 88,2% eram CCEs-BD e 11,8% eram MD; na região média, 60% eram BD, 20% eram MD e 20% eram PD; na região caudal, 50% eram BD, 27,8% MD e 22,2% PD. Metástases ocorreram em 57,75% dos casos, principalmente para linfonodos regionais, e foram observadas em 58,82% dos CCEs na região cranial, em 40% dos da região média e em 61,11% dos da região caudal. Metástases para linfonodos regionais e/ou órgãos distantes foram encontradas em 44,44% dos CCEs-BD, em 75% dos MD e em 100% os PD. Foram analisados os padrões de migração e invasão com o auxílio da técnica de imunoistoquímica para citoqueratina. Nos CCEs-BD predominaram os padrões em ilhas e fitas de queratinócitos neoplásicos; nos MD os padrões variaram muito porém predominaram os agregados pequenos, fitas e cordões; nos PD predominaram os agregados e as células individuais. Invasão vascular linfática e/ou sangüínea foram observadas em 11/40 CCEs. Foram observados CCEs originando-se do epitélio dos ductos das glândulas salivares, aspecto este que não havia sido relatado anteriormente. Observou-se que a intensidade do IILP era muito mais acentuada nos CCEs-BD que nos MD e PD. A intensidade da reação desmoplásica foi quantificada através da imunistoquímica para vimentina e foi muito mais acentuada nos CCEs-PD. A TATE foi medida nos CCEs quanto à intensidade em leve, moderada ou acentuada. A única associação positiva estatisticamente significativa foi estabelecida entre a intensidade da TATE e a do IILP. A proliferação celular foi avaliada quantitativamente através da contagem das regiões organizadoras nucleolares argirofílicas (AgNORs) nos queratinócitos neoplásicos. A média e o desvio padrão (±DP) de AgNORs nos CCEs BD foi de 1,65 (±0,23), nos MD de 1,88 (±0,31) e nos PD foi de 2,39 (±0,26). A correlação entre o índice de AgNOR e cada grau de diferenciação celular foi estatisticamente significativa. Concluiu-se que os fatores que influenciaram no comportamento biológico dos CCEs foram o grau de diferenciação celular, os padrões de migração e invasão, a IILP, a TATE e da reação desmoplásica e o índice de proliferação celular avaliado através da contagem das AgNORs.

Beside tumor cells themselves, tumors consist of many non-malignantly transformed cellular elements and an extracellular matrix. This so-called tumor microenvironment, or stroma, significantly influences the biological properties of the tumor through intercellular interactions. In this thesis I have focused on the study of tumor-associated fibroblasts in squamous cell carcinomas of the head and neck, malignant melanoma and glioblastoma. The data show the presence of cells with mesenchymal characteristics, present even in the glioblastoma stroma, which could potentially have a positive effect on proliferative activity and invasiveness of glioblastoma cells. In malignant melanoma, the presence of keratinocytes should also be considered, as they are the major cells of the epidermis influencing tumor melanocytes. The conditioned medium from UVB irradiated keratinocytes and non-irradiated fibroblasts stimulates the invasion of malignant melanoma cells. Targeting the tumor stroma may be a new direction in oncological therapy, so we have focused on the influence of synthetic polyamine on the formation of myofibroblasts, which are an active part of the population of tumor-associated fibroblasts. The tested polyamine prevents the formation of myofibroblasts but has no effect on those already formed nor on...

Wnt/beta-Catenin-Signalgebung hat große Bedeutung für die Initiation und Progression verschiedener Krebsarten. Unser Labor hat kürzlich ein Mausmodell für Squamöse Speicheldrüsen-Karzinome etabliert, das menschliche Hals-Nasen-Ohren-Karzinome reflektiert, durch kombinierte Mutationen von beta-Catenin und dem Bmp-Rezeptor 1a. Diese Tumore enthielten hohen Level von sich selbst-erneuernden Krebs-Stammzellen. Behandlung mit den Wnt-Inhibitoren ICG-001 blockierte die Selbsterneuerung und induzierte die Differenzierung der Krebs-Stammzellen. In den Krebs-Stammzellen der Maus wurde eine globale Aufregulierung des Histonmarkers H3K4me3 beobachtet, was durch Wnt-Inhibition gehemmt werden konnte. Um die molekularen Mechnismen aufzuklären, wurden die Histon-Methyltransferasen für H3K4me3, d.h., Mitglieder der Mll-Proteinfamilie, in sphären-kultivierten Krebs-Stammzellen durch RT-PCR analysiert: Mll1 war hoch transkribiert, zusammen mit den Hoxa9- und Meis1-Zielgenen. Interessanterweise aktivierte die Expression von Mll1 durch Wnt-Signalgebung die distale Enhancer-Region von Mll1, was durch Luciferase-Reporter-Assays gemessen wurde. Immunopräzipitation zeigte weiter, dass Mll1 im beta-Catenin-Transcriptionsfaktor-Komplex involviert ist: shRNA-Behandlung von Mll1 reduzierte die Sphären-Bildung der Speicheldrüsen-Krebs-Stammzellen der Maus. In doppelt-mutanten Mäusen hat die zusätzliche genetische Ablation von Mll1 die Tumorbildung verhindert und die Selbsterneuerung der Krebs-Stammzellen reduziert. Diese Daten zeigen dass die beta-Catenin-Mll1-Achse die Selbsterneuerung der Stammzellen antreibt und deren Differenzierung verhindert, und zwar via epigenetische Mechanismen. Deshalb wird durch das Targeting von Mll1 und dessen Interaktion mit beta-Catenin und andern Komponenten den gesunden epigenetischen Zustand in den Stammzellen wieder herstellt, was eine neue und vielversprechende Möglichkeit für die Behandlung von Patienten mit Hals-Nasen-Ohren-Tumoren darstellt. / Wnt/beta-catenin signaling has been implicated in the initiation and progression of various human cancers. Our lab has recently established a mouse model of salivary gland squamous cell carcinomas (SCCs), which resembles human head and neck cancer, by combined gain- and loss-of-function mutations of beta-catenin and the Bmp receptor 1a (double mutant tumors). These tumors contained highly self-renewing cancer stem cells (CSCs) that were Wnt-dependent. Treatment with the Wnt inhibitor ICG-001 (interferes with beta-catenin-CBP-Mll1 interaction) blocked the self-renewal and induced differentiation of CSCs. In the mouse salivary gland CSCs, a global up-regulation of the histone mark H3K4me3 was observed, which could be suppressed by Wnt inhibition. To study the potential molecular mechanisms, the H3K4me3 histone methyl-transferases, i.e., members of the Mll protein family were analyzed in freshly isolated, sphere-cultured CSCs by RT-PCR: Mll1 was highly transcribed, together with its target genes Hoxa9 and Meis1. Interestingly, the expression of Mll1 was upregulated by Wnt signaling by activating its distal enhancer regions, which was seen with Luciferase reporter assays. Immuno-precipitation further showed that Mll1 is involved in the beta-catenin/Tcf4 transcription factor complex: shRNA treatment against Mll1 reduced sphere formation of mouse salivary gland CSCs. In double mutant mice, additional genetic ablation of Mll1 (triple mutant tumors) abrogated tumor formation and affected the self-renewal ability of CSCs. Collectively, the data presented in this study show that the beta-catenin-Mll1 axis drives self‐renewal and fends off differentiation of CSCs via epigenetic mechanisms. Therefore, targeting Mll1 or its interaction with beta-catenin and other components may help to restore a healthy epigenetic state in the stem cells, which represent a novel and promising therapeutic approach for the treatment of head and neck SCCs.

No description available.